 Intercept Pharmaceuticals Inc NASDAQ:ICPT Analysts at Piper Sandler reduced their Q3 2020 earnings estimates for shares of Intercept Pharmaceuticals in a research note issued to investors on Monday, August 24th. Piper Sandler analyst Y. Rahimi now forecasts that the biopharmaceutical company will earn 1.94 per share for the quarter, down from their prior estimate ... 